12.92
+2.78%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Take Solutions
Its shares trade on NSE under the ticker TAKE.NS. It has been listed since 27 August 2007. In the fiscal year to 31 March 2026, it reported revenue of ₹541.9m and net income of ₹108.5m. At that date it held total assets of ₹362.4m and shareholders' equity of ₹310.0m.
TAKE Solutions Ltd. engages in the provision of end-to-end services and solutions in the domain of Life Sciences. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2007-08-27. The firm operates through two segments: Life Sciences and Supply Chain Management. The company offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. The company provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks, and consulting to deliver end-to-end solutions and services across processes, technology, and analytics to both domestic and global clients. The company also provides information technology (IT) infrastructure and support, engineering, designing, and sourcing services. The firm operates in North America, Europe, Asia, and South America.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 27 Aug 2007
- Employees
- 211
- Website
- takesolutions.com ↗
Leadership
Pay as last reported
- Mr. Venkatesan VedamirthamChief Financial Officer
- Shri. Harikesavanallur SrinivasanAdditional Non-Executive Director₹1.4m
- Mr. N. ChandrasekaranAdditional Independent Director
- Mr. Ramesh GopalAdditional Independent Director
- Mr. Rangasami SeshadriAdditional Independent Director, since 2022₹2.3m
- Mr. Rangaswamy Sundara RajanIndependent Director
- Ms. Kiran SharmaAdditional Non-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- End-to-end services in Life Sciences sector across clinical, regulatory, and safety domains.
- 211 full-time employees supporting diverse client needs in global markets.
- Operates through two key segments: Life Sciences and Supply Chain Management.
Weaknesses
- Headquartered in Chennai, Tamil Nadu, limiting local market access.
- IPO listed on 27 August 2007, indicating long-standing market presence.
- Services span clinical trials to post-marketing safety, requiring continuous regulatory updates.
Opportunities
- Expanding into North America, Europe, Asia, and South America markets.
- Growing demand for clinical research and pharmacovigilance services globally.
- Leveraging IT infrastructure to enhance data sciences and analytics offerings.
Threats
- Regulatory changes in global markets affecting clinical trial processes.
- Competition from established firms in Life Sciences sector.
- Economic downturns impacting client spending on clinical and regulatory services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.